• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2016 Institute of Health Economics (IHE) Hysteroscopic tubal sterilization (using the Essure® system) – an update
2016 NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-α-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn's disease: systematic reviews and economic modelling
2016 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Iontophoresis assisted corneal crosslinking]
2016 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Safety and effectiveness of LDL-aphaeresis in cerebrotendinous xanthomatosis]
2016 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness and safety of irreversible electroporation in the treatment of of cancers of the liver and pancreas. Systematic review. Update]
2016 Belgian Health Care Knowledge Centre (KCE) Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Fundus autofluorescence for the diagnosis of retinopathies
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Calcium dobesilate for the treatment of chronic venous insufficiency
2016 Institute for Clinical Effectiveness and Health Policy (IECS) lntravitreal glucocorticoids in posterior retina conditions
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Endoscopic ultrasound elastography
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Endobutton® and Retrobutton® for femoral fixation of the anterior cruciate ligament graft
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Nivolumab for the treatment of renal-cell carcinoma
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Dextrometorphan-quinidine for the treatment of pseudobulbar affect
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Multiplex PCR panels (FilmArray®) to diagnose infections
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Fractional exhaled nitric oxygen in asthma patients
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Extracorporeal shock wave therapy in musculoskeletal disorders
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Botulinum toxin for sialorrhea
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Magnetic resonance neurography to study peripheral neuropathies
2016 Institute for Clinical Effectiveness and Health Policy (IECS) High-dose chemotherapy followed by autologous transplantation of hematopoietic stem cells in patients with recurrent childhood medulloblastoma
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Cannabinoids for refractory epilepsy treatment
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Percutaneous closure of patent foramen ovale for stroke prevention
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Activated charcoal for preoperative localization of thyroid cancer recurrence
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Cryoablation for the treatment of kidney tumors
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Rituximab biosimilars
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Biomedical treatment for autism spectrum disorders
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Use of anti-neuronal antibodies to diagnose paraneoplastic neurological syndromes
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Eye tracking speech-generating devices in disorders involving language, speech and motor skills
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Riociguat for the treatment of pulmonary hypertension
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Radio-223 (Xofigo®) for the treatment of patients with metastatic cancer
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Single-use negative pressure wound therapy for chronic and acute wounds
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Stem cell therapy in heart failure prevention and progress
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Nivolumab for the treatment of non-small cell lung cancer
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Nivolumab in advanced melanoma treament
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Glifing method to treat dyslexia
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Magnetic resonance imaging with tractography for brain white matter diseases
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Percutaneous epidural neurolysis and endoscopic neurolysis for the treatment of chronic low back pain
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Trigeminal nerve stimulation to treat neuralgia
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Pembrolizumab for the treatment of advanced melanoma
2016 NIHR Health Technology Assessment programme The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation
2016 NIHR Health Technology Assessment programme Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis
2016 Health Quality Ontario (HQO) Levonorgestrel-releasing intrauterine sSystem (52 mg) for idiopathic heavy menstrual bleeding: a health technology assessment
2016 Health Quality Ontario (HQO) Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment
2016 Health Quality Ontario (HQO) Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment
2016 Health Quality Ontario (HQO) Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation
2016 Health Quality Ontario (HQO) Levonorgestrel-releasing intrauterine system (52 mg) for idiopathic heavy menstrual bleeding: OHTAC Recommendation
2016 Health Quality Ontario (HQO) Transcatheter aortic valve implantation for treatment of aortic valve stenosis: OHTAC recommendation
2016 NIHR Public Health Research (PHR) programme IMPRoving Outcomes for children exposed to domestic ViolencE (IMPROVE): an evidence synthesis
2016 NIHR Health Services and Delivery Research programme Getting the most out of knowledge and innovation transfer agents in health care: a qualitative study
2016 NIHR Health Services and Delivery Research programme Location of care for people with serious mental illness (LOCAPE): implications for service use and costs using a mixed-methods approach
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Models for providing care and services to patients who have concurrent mental health and substance use disorders]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Impact evaluation of optimal use guidelines implementation for self-monitoring of blood glucose by adult patients with type 2 diabetes and not using insulin]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides for the pharmacological treatment of STBBIs]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Extracorporeal photopheresis: main indications and implementation parameters]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal long-term use of proton pump inhibitors]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Rectal cancer investigation, treatment and follow-up algorithm]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Colon cancer investigation, treatment and follow-up algorithm (update)]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Feasibility and appropriateness of implementing satellite radiotherapy centres equipped with a single linear accelerator]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Evidence brief on the measures related to the reimbursement of blood glucose test strips]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Effect of palivizumab prophylaxis in reducing the complications associated with the respiratory syncytial virus in infants and young children]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Circulating tumour cells in breast cancer: clinical use of the CellSearch® test]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical practice guidelines for the rehabilitation of adults having sustained a moderate to severe traumatic brain injury: development process and recommendations]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical guides in antibiotic treatment – 1st series (update)]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Economic evaluation of the molecular diagnosis of the influenza virus]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Evaluation of subcutaneous-lead implantable cardioverter-defibrillators]
2016 Institut national d'excellence en sante et en services sociaux (INESSS) [Use of radioactive seeds for the preoperative localization of non-palpable breast tumours]
2016 HAYES, Inc. Balloon sinuplasty for treatment of chronic rhinosinusitis
2016 HAYES, Inc. Comparative effectiveness of bivalirudin versus heparin monotherapy for percutaneous coronary intervention (PCI)
2016 HAYES, Inc. Electrical bone growth stimulation, invasive
2016 HAYES, Inc. High-frequency chest wall compression for diseases other than cystic fibrosis
2016 HAYES, Inc. Hyperbaric oxygen therapy for sudden sensorineural hearing loss
2016 HAYES, Inc. Indwelling pleural catheters for the management of malignant pleural effusions
2016 HAYES, Inc. Minimally invasive surgical (MIS) procedures for treatment of atrial fibrillation
2016 HAYES, Inc. Minimally invasive transforaminal lumbar interbody fusion (mitlif) versus open transforaminal lumbar interbody fusion (otlif) for treatment of lumbar disc disease: a review of reviews
2016 HAYES, Inc. Nitric oxide breath analysis for the management of asthma
2016 HAYES, Inc. Noninvasive computed fractional flow reserve from computed tomography (FFRCT) for coronary artery disease
2016 HAYES, Inc. Noninvasive electrical bone growth stimulators for spinal fusion or foot and ankle indications
2016 HAYES, Inc. Patient-specific instruments for total knee arthroplasty: a review of reviews
2016 HAYES, Inc. Ultrasound-guided high-intensity focused ultrasound for primary treatment of localized prostate cancer
2016 HAYES, Inc. 5-aminolevulinic acid photodynamic therapy versus carbon dioxide laser ablation for the treatment of condylomata acuminata
2016 HAYES, Inc. Amniotic tissue–derived allografts for treatment of plantar fasciitis
2016 HAYES, Inc. Bupivacaine liposome injectable suspension (Exparel; Pacira Pharmaceuticals Inc.) for treatment of postoperative pain in abdominal surgeries
2016 HAYES, Inc. Carbon dioxide (CO2) laser ablation versus other surgical treatment of condylomata acuminata
2016 HAYES, Inc. Fecal microbiota transplant for refractory or recurrent Clostridium difficile infection in adults
2016 HAYES, Inc. Intersitial brachytherapy for the treatment of nonmelanoma skin cancer
2016 HAYES, Inc. Laser balloon ablation for treatment of atrial fibrillation
2016 HAYES, Inc. Low frequency right transcranial magnetic stimulation for major depressive disorder
2016 HAYES, Inc. Magnetic resonance-guided focused ultrasound therapy (ExAblate 2000; InSightec Ltd.) for ablation of uterine fibroids
2016 HAYES, Inc. NanoKnife system for irreversible electroporation treatment of locally advanced pancreatic cancer
2016 HAYES, Inc. NanoKnife system for irreversible electroporation treatment of primary and metastatic liver tumors
2016 HAYES, Inc. Surface brachytherapy for the treatment of nonmelanoma skin cancer
2016 HAYES, Inc. UroLift System (NeoTract Inc.) for treatment of benign prostatic hyperplasia
2016 HAYES, Inc. Verasense (OrthoSensor Inc.) for use during total knee arthroplasty
2016 HAYES, Inc. Guardant360 (Guardant Health Inc.)
2016 HAYES, Inc. Oncotype DX DCIS Breast Cancer Test (Genomic Health Inc.)
2016 HAYES, Inc. Oncotype DX Genomic Prostate Score (GPS) Assay (Genomic Health Inc.)
2016 HAYES, Inc. Accelerated partial breast irradiation for breast cancer using brachytherapy
2016 HAYES, Inc. Accelerated partial breast irradiation for breast cancer using conformal and intensity-modulated radiation therapy
2016 HAYES, Inc. Brachytherapy as an adjunct to other types of radiation therapy for breast cancer